Effects of miR-193a and sorafenib on hepatocellular carcinoma cells

Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell

(2012) Ning Xu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Molecular mechanisms of sorafenib action in liver cancer cells

(2012) Melchiorre Cervello et al.   CELL CYCLE

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Inhibition of miR-193a Expression by Max and RXR  Activates K-Ras and PLAU to Mediate Distinct Aspects of Cellular Transformation

(2011) D. Iliopoulos et al.   CANCER RESEARCH

DNA Methylation-regulated miR-193a-3p Dictates Resistance of Hepatocellular Carcinoma to 5-Fluorouracil via Repression of SRSF2 Expression

(2011) Kelong Ma et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The role of microRNAs in liver cancer progression

(2010) S Huang et al.   BRITISH JOURNAL OF CANCER

Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy

(2010) J Rafael Sierra et al.   Molecular Cancer

Efficient in vivo microRNA targeting of liver metastasis

(2010) C Huynh et al.   ONCOGENE

Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model

(2009) Janaiah Kota et al.   CELL

MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells

(2009) Alessandro Salvi et al.   FEBS Journal

MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib

(2009) Shoumei Bai et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

(2009) C Coulouarn et al.   ONCOGENE

miR-221 overexpression contributes to liver tumorigenesis

(2009) P. Pineau et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival

(2008) J. Jiang et al.   CLINICAL CANCER RESEARCH

MicroRNA expression profiling: A molecular tool for defining the phenotype of hepatocellular tumors

(2008) Chiara Braconi et al.   HEPATOLOGY

Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target

(2008) Yu Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

(2008) Abby B. Siegel et al.   JOURNAL OF CLINICAL ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE